Source: EURLEX
Language: en
Format: md

|  |  |  |  |
| --- | --- | --- | --- |
| 16.8.2021 | EN | Official Journal of the European Union | C 329/36 |

---

Action brought on 23 June 2021 — Hecht Pharma v EUIPO — Gufic Biosciences (Gufic)

(Case T-346/21)

(2021/C 329/47)

Language in which the application was lodged: German

Parties

Applicant: Hecht Pharma GmbH (Bremervörde, Germany) (represented by: C. Sachs and J. Sachs, lawyers)

Defendant: European Union Intellectual Property Office (EUIPO)

Other party to the proceedings before the Board of Appeal: Gufic Biosciences Ltd. (Mumbai, India)

Details of the proceedings before EUIPO

Proprietor of the trade mark at issue: Other party to the proceedings before the Board of Appeal

Trade mark at issue: EU word mark Gufic — EU trade mark No 8 613 044

Procedure before EUIPO: Cancellation proceedings

Contested decision: Decision of the Second Board of Appeal of EUIPO of 3 June 2021 in Case R 2738/2019-2

Form of order sought

The applicant claims that the Court should:

|  |  |
| --- | --- |
| — | annul the contested decision and also declare EU trade mark No 8 613 044 ‘Gufic’ revoked in respect of Class 5 ‘Medicines’; |

|  |  |
| --- | --- |
| — | order Gufic Biosciences Ltd. to pay the costs of the appeal proceedings and of the pre-litigation procedure. |

Plea in law

|  |  |
| --- | --- |
| — | Infringement of Article 58(1) of Regulation (EU) 2017/1001 of the European Parliament and of the Council. |

---

[Top](#document1)